PRESS RELEASE Ghent, Belgium – 2 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, will announce its full year results ended 31 December 2022 on Thursday, 9 February 2023. The management team will...Read More